in ,

Covishield prices announced: Rs 400 for state governments, Rs 600 to pvt hospitals

News Agencies

New Delhi: Serum Institute of India (SII) on Wednesday announced that it will charge state governments Rs 400 and private hospitals Rs 600 per dose of its Covishield COVID-19 vaccine, finally answering the question of how the company expects to price the product it manufactures and accelerate India’s vaccination drive.

The Serum Institute produces Covishield, the COVID-19 vaccine developed by Oxford University and AstraZeneca. Covishield is among the three COVID-19 vaccines authorised for emergency use in India.

The company said 50 percent of its capacities will serve the government of India’s vaccination programme, and the remaining 50 percent capacity will be for state governments and private hospitals.

“For the next two months, we will address the limited capacity by scaling up the vaccine production,” it said in a statement.

Serum Institute, the world’s largest vaccine manufacturer, said doses will be made available in retail and for free trade after four-five months.

Citing “complexity and urgency of the situation” and challenges in supplying doses independently to corporate entities, the Serum Institute urged corporates and private individuals to access vaccines through the state-facilitated machinery and private health systems.

Everyone above 18 years of age will be eligible to get vaccinated against COVID-19 from May 1, the Centre had announced on April 19.


Leave a Reply

Your email address will not be published. Required fields are marked *



With 2.95 lakh Covid cases, 2,023 deaths; India sees biggest daily spike

KCCI Elections: Hope21 and Kashmir21 spell out agendas and priorities